Trial intelligence / Profile preview

Oral tranexamic acid before vaginal delivery for prevention of postpartum hemorrhage

2020-002015-22Phase 4Completed

Sponsor
Södersjukhuset Department of Obstetrics and Gynecology
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in postpartum hemorrhage (PPH) comparing Oral tranexamic acid prepartum with Placebo (2 arms). Primary endpoints: Rate of postpartum hemorrhage of at least 500 mL and Postpartum hemoglobin decrease greater than 10 units. Started Jun 2021; status: completed.

02

Drugs

tranexamic acid
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on 2020-002015-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-002015-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call